Search Results - Germing, Ulrich

Refine Results
  1. 1
    Correspondence (reply): In Reply

    Correspondence (reply): In Reply by Germing, Ulrich

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Reply to “Acute leukemia arising after radioiodine treatment for thyroid cancer” Haematologica 2012;97(8):e28–29

    Reply to “Acute leukemia arising after radioiodine treatment for thyroid cancer” Haematologica 2012;97(8):e28–29 by Schroeder, Thomas, Germing, Ulrich

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Mastering the multitude of monocytoses

    Mastering the multitude of monocytoses by Germing, Ulrich, Gattermann, Norbert

    Published 2019
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview

    Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview by Kuendgen, Andrea, Kasprzak, Annika, Germing, Ulrich

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment

    Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment by Germing, Ulrich, Kobbe, Guido, Haas, Rainer, Gattermann, Norbert

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Mesenchymal stromal cells in myeloid malignancies

    Mesenchymal stromal cells in myeloid malignancies by Schroeder, Thomas, Geyh, Stefanie, Germing, Ulrich, Haas, Rainer

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)

    Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS) by Kasprzak, Annika, Nachtkamp, Kathrin, Gattermann, Norbert, Germing, Ulrich

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies

    Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies by Germing, Ulrich, Oliva, Ester N., Hiwase, Devendra, Almeida, Antonio

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes

    Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes by Giagounidis, Aristoteles A N, Germing, Ulrich, Haase, Sabine, Aul, Carlo

    Published 2007
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): A case report

    A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with g... by Schroeder, Thomas, Hildebrandt, Barbara, Mayatepek, Ertan, Germing, Ulrich, Haas, Rainer

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment

    Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment by Rautenberg, Christina, Germing, Ulrich, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Impaired formation of neutrophil extracellular traps in patients with MDS

    Impaired formation of neutrophil extracellular traps in patients with MDS by Brings, Carolin, Fröbel, Julia, Cadeddu, Patrick, Germing, Ulrich, Haas, Rainer, Gattermann, Norbert

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival

    Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival by Czibere, Akos, Bruns, Ingmar, Junge, Bärbel, Singh, Raminder, Kobbe, Guido, Haas, Rainer, Germing, Ulrich

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?

    Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action? by Kasprzak, Annika, Kaivers, Jennifer, Nachtkamp, Kathrin, Haas, Rainer, Kobbe, Guido, Gattermann, Norbert, Germing, Ulrich

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

    Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes by Giagounidis, Aristoteles, Mufti, Ghulam J., Fenaux, Pierre, Germing, Ulrich, List, Alan, MacBeth, Kyle J.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome by Zipperer, Esther, Pelz, Daniela, Nachtkamp, Kathrin, Kuendgen, Andrea, Strupp, Corinna, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

    Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients by Silzle, Tobias, Blum, Sabine, Schuler, Esther, Kaivers, Jennifer, Rudelius, Martina, Hildebrandt, Barbara, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

    The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system by Zipperer, Esther, Tanha, Nina, Strupp, Corinna, Kündgen, Andrea, Nachtkamp, Kathrin, Neukirchen, Judith, Hildebrandt, Barbara, Haas, Rainer, Gattermann, Norbert, Germing, Ulrich

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS

    Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS by Rautenberg, Christina, Germing, Ulrich, Pechtel, Sabrina, Lamers, Marius, Fischermanns, Carolin, Jäger, Paul, Geyh, Stefanie, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

    Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectation... by Boquoi, Amelie, Rings, Veronika, Mohring, Annemarie, Savickaite, Ingrida, Zukovs, Romans, Strapatsas, Judith, Nachtkamp, Kathrin, Kobbe, Guido, Germing, Ulrich, Fenk, Roland

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: